Bianca Seminotti, PhD is the 2026 recipient of the ACMG Foundation Early Career Travel Award. The ACMG Foundation for Genetic and Genomic Medicine  selected Dr. Seminotti based on her abstract ...
Opus Genetics, Inc. announced that three abstracts concerning its investigational gene therapy candidates will be presented at the ARVO 2025 Meeting in Salt Lake City, UT, from May 4-8, 2025. The ...
Eva Vailionis, MS, CGC is the 2026 recipient of the ACMG Foundation Genetic Counselor Best Abstract Award. The ACMG Foundation for Genetic and Genomic Medicine selected Ms. Vailionis based on her ...
XORTX Therapeutics (XRTX) announces a presentation by Dr. Allen Davidoff at the Rare and Genetic Kidney Disease Summit, in Boston, Massachusetts at 10:30 am ET, Thursday December 12, 2024. The ...
RESEARCH TRIANGLE PARK, N.C., May 05, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (IRD) (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of ...
For more information on SLEEP 2024, please refer to https://www.sleepmeeting.org/ About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines ...